Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Dimethylacetamide

From Wikipedia, the free encyclopedia
(Redirected fromN,N-Dimethylacetamide)
Dimethylacetamide
Skeletal formula of dimethylacetamide
Skeletal formula of dimethylacetamide
Ball and stick model of dimethylacetamide
Ball and stick model of dimethylacetamide
Names
Preferred IUPAC name
N,N-Dimethylacetamide
Identifiers
3D model (JSmol)
AbbreviationsDMA, DMAC, DMAc[1]
1737614
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard100.004.389Edit this at Wikidata
EC Number
  • 204-826-4
MeSHdimethylacetamide
RTECS number
  • AB7700000
UNII
  • InChI=1S/C4H9NO/c1-4(6)5(2)3/h1-3H3 checkY
    Key: FXHOOIRPVKKKFG-UHFFFAOYSA-N checkY
  • CN(C)C(C)=O
Properties
C4H9NO
Molar mass87.122 g·mol−1
AppearanceColorless liquid
OdorAmmoniacal
Density0.937 g/mL
Melting point−20 °C (−4 °F; 253 K)
Boiling point165.1 °C; 329.1 °F; 438.2 K
Miscible
logP−0.253
Vapor pressure300 Pa
UV-vismax)270 nm
1.4375
Viscosity0.945 mPa·s[2]
Thermochemistry
178.2 J/(K·mol)
−300.1 kJ/mol
−2.5835–−2.5805 MJ/mol
Hazards
GHS labelling:
GHS07: Exclamation markGHS08: Health hazard
Danger
H312,H319,H332,H360
P280,P308+P313
NFPA 704 (fire diamond)
Flash point63 °C (145 °F; 336 K)
490 °C (914 °F; 763 K)
Explosive limits1.8–11.5%
Lethal dose or concentration (LD, LC):
2.24 g/kg(dermal, rabbit)
4.3 g/kg(oral, rat)
4.8 g/kg (oral, rat)
4.62 g/kg (oral, mouse)[4]
2475 ppm (rat, 1 h)[4]
NIOSH (US health exposure limits):
PEL (Permissible)
TWA 10 ppm (35 mg/m3) [skin][3]
REL (Recommended)
TWA 10 ppm (35 mg/m3) [skin][3]
IDLH (Immediate danger)
300 ppm[3]
Related compounds
Related compounds
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

Dimethylacetamide (DMAc orDMA) is theorganic compound with theformula CH3C(O)N(CH3)2. This colorless, water-miscible, high-boiling liquid is commonly used as a polarsolvent inorganic synthesis. DMA is miscible with most other solvents, although it is poorly soluble inaliphatichydrocarbons.

Synthesis and production

[edit]

DMA is prepared commercially by the reaction ofdimethylamine withacetic anhydride oracetic acid. Dehydration of the salt of dimethylamine and acetic acid also furnishes this compound:[5]

CH3CO2H·HN(CH3)2 → H2O + CH3CON(CH3)2

Dimethylacetamide can also be produced by the reaction ofdimethylamine withmethyl acetate.[6]

One route to dimethylacetamide

The separation and purification of the product is carried out by multistagedistillation in rectification columns. DMA is obtained with essentially quantitive (99%)yield referred to methyl acetate.[6]

Reactions and applications

[edit]

The chemical reactions of dimethylacetamide are typical ofN,N-disubstitutedamides.Hydrolysis of the acyl-N bond occurs in the presence ofacids:

CH3CON(CH3)2 + H2O + HCl → CH3COOH + (CH3)2NH2+Cl

However, it is resistant to bases. For this reason DMA is a useful solvent for reactions involving strong bases such assodium hydroxide.[7]

Dimethylacetamide is commonly used as a solvent for fibers (e.g.,polyacrylonitrile,spandex) or in theadhesive industry.[5] It is also employed in the production ofpharmaceuticals andplasticizers as a reaction medium.

A solution oflithium chloride in DMAc (LiCl/DMAc) can dissolvecellulose. Unlike many other cellulose solvents, LiCl/DMAc gives a molecular dispersion, i.e. a "true solution". For this reason, it is used ingel permeation chromatography to determine themolar mass distribution of cellulose samples.

Dimethylacetamide is also used as anexcipient in drugs, e.g. in Vumon (teniposide), Busulfex (busulfan) or Amsidine (amsacrine).

Toxicity

[edit]

Dimethylacetamide, like most simple alkyl amides, is of low acute toxicity. Chronic exposure can causehepatotoxicity.[8][9][10][11] At high doses (400 mg/kg body mass daily), dimethylacetamide causes effects on thecentral nervous system (e.g.depression,hallucinations anddelusion).[8][12][13]

Dimethylacetamide may be incompatible withpolycarbonate orABS. Devices (e.g. syringes) that contain polycarbonate or ABS can dissolve when coming into contact with dimethylacetamide.[14]

Regulation

[edit]

In 2011, dimethylacetamide was identified in the EU as aSubstance of very high concern (SVHC) because of itsreproductive toxicity.[15] In 2014, the European Commission has started an investigation to restrict the use of dimethylacetamide in the EU according toREACH.[16]

In 2015, the CNESST (Committee on Standards, Equity, Health and Safety at Work inQuebec) has adopted a tightened classification of dimethylacetamide:[17]

DescriptionCategoryGHS hazard statement
Reproductive toxicity2Suspected of damaging fertility or the unborn child (H361)
Specific target organ toxicity – repeated exposure2May cause damage to organs through prolonged or repeated exposure (H373)
Serious eye damage/eye irritation2Causes serious eye irritation (H319)
Acute toxicity – inhalation3Toxic if inhaled (H331)
Specific target organ toxicity – single exposure – narcotic effects3May cause drowsiness or dizziness (H336)
Flammable liquid4Combustible liquid (H227)

See Also

[edit]

References

[edit]
  1. ^Munro, D. D.; Stoughton, R. B. (1965). "Dimethylacetamide (DMAC) and Dimethylformamide (DMFA). Effect on Percutaneous Absorption".Archives of Dermatology.92 (5):585–586.doi:10.1001/archderm.1965.01600170101020.PMID 5844405.
  2. ^Iloukhani, H., K. Khanlarzadeh. "Densities, viscosities, and refractive indices for binary and ternary mixtures of N, N-dimethylacetamide (1)+ 2-methylbutan-2-ol (2)+ ethyl acetate (3) at 298.15 K for m liquid region and at ambient pressure". Journal of Chemical & Engineering Data, 51.4 (2006): 1226–1231.doi:10.1021/je050538q.
  3. ^abcNIOSH Pocket Guide to Chemical Hazards."#0218".National Institute for Occupational Safety and Health (NIOSH).
  4. ^ab"Dimethyl acetamide".Immediately Dangerous to Life or Health Concentrations (IDLH).National Institute for Occupational Safety and Health (NIOSH).
  5. ^abCheung, H.; Tanke, R. S.; Torrence, G. P. "Acetic Acid".Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH.doi:10.1002/14356007.a01_045.pub2.ISBN 978-3-527-30673-2.
  6. ^abGrafmans, Horst; Maas, Steffen; Weck, Alexander; Rütter, Heinz; Schulz, Michael; Ross, Karl-Heinz."Method for the production of n,n-dimethylacetamide (DMAC)".Google Patents. BASF SE. Retrieved18 July 2019.
  7. ^Zen, S.; Kaji, E. (1977)."Dimethyl nitrosuccinate".Organic Syntheses.57: 60;Collected Volumes, vol. 6, p. 503.
  8. ^abU.S. Department of Health and Human Services & U.S. Department of Labor (1978)Occupational Health Guideline for Dimethyl Acetamide. Now: Occupational Health Guideline for Chemical Hazards.DHHS (NIOSH) Publication Number 81-123. January 1981. The National Institute for Occupational Safety and Health (NIOSH).
  9. ^Baum, S. L.; Suruda, A. J. (1997). "Toxic Hepatitis from Dimethylacetamide".International Journal of Occupational and Environmental Health.3 (1):1–4.doi:10.1179/oeh.1997.3.1.1.PMID 9891094.
  10. ^Lee, C.-Y.; Jung, S.-J.; Kim, S.-A.; Park, K.-S.; Ha, B.-G. (2006)."Incidence of dimethylacetamide induced hepatic injury among new employees in a cohort of elastane fibre workers".Occupational and Environmental Medicine.63 (10):688–693.doi:10.1136/oem.2005.023580.PMC 2078052.PMID 16728503.
  11. ^Gong, W.; Liu, X.; Zhu, B. (2016)."Dimethylacetamide-induced occupational toxic hepatitis with a short term recurrence: a rare case report".Journal of Thoracic Disease.8 (6):E408 –E411.doi:10.21037/jtd.2016.04.44.PMC 4885965.PMID 27293868.
  12. ^Weiss, A. J.; Jackson, L. G.; Carabasi, R. A.; Mancall, E. L.; White, J. C. (1962). "A Phase I Study of Dimethylacetamide".Cancer Chemotherapy Reports.16 (February 1962):477–485.PMID 14005853.
  13. ^Weiss, A. J.; Mancall, E. L.; Koltes, J. A.; White, J. C.; Jackson, L. G. (1962). "Dimethylacetamide: A Hitherto Unrecognized Hallucinogenic Agent".Science.136 (3511):151–152.Bibcode:1962Sci...136..151W.doi:10.1126/science.136.3511.151.PMID 14005854.S2CID 20098340.
  14. ^FDA warns health care professionals not to use Treanda Injection (solution) with closed system transfer devices, adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene. 10 March 2015.
  15. ^Agreement of the Member State Committee on the Identification of N,N-Dimethylacetamide (DMAC) as a Substance of Very High Concern – Adopted on 24 November 2011.
  16. ^Commission Regulation (EU) No 895/2014, Official Journal of the European Union, 19.08.2014.
  17. ^Commission des normes, de l'équité, de la santé et de la sécurité du travail (CNESST), Quebec, Canada:WHMIS 2015 classification of N,N-Dimethylacetamide.

External links

[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Dimethylacetamide&oldid=1263904784"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp